RIF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.616400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.100200E-01
Normal-vs-Stage2
9.218200E-01
Normal-vs-Stage3
1.192440E-01
Normal-vs-Stage4
3.752000E-01
Stage1-vs-Stage2
8.533400E-01
Stage1-vs-Stage3
1.581010E-01
Stage1-vs-Stage4
1.872810E-01
Stage2-vs-Stage3
1.631440E-01
Stage2-vs-Stage4
1.967800E-01
Stage3-vs-Stage4
2.159700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.205200E-01
Normal-vs-AfricanAmerican
5.674000E-01
Normal-vs-Asian
5.019000E-01
Caucasian-vs-AfricanAmerican
8.856100E-02
Caucasian-vs-Asian
3.159400E-01
AfricanAmerican-vs-Asian
1.177640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.744400E-01
Normal-vs-Female
8.546600E-01
Male-vs-Female
9.930200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.931400E-01
Normal-vs-Age(41-60Yrs)
7.922400E-01
Normal-vs-Age(61-80Yrs)
7.099200E-01
Normal-vs-Age(81-100Yrs)
4.226600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.291600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.459400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.376600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.394500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.429700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.808000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.508400E-01
Normal-vs-Daily Drinker
4.051800E-01
Normal-vs-Weekly Drinker
5.993600E-01
Normal-vs-Occasional Drinker
8.707000E-01
Normal-vs-Social Drinker
8.178200E-01
Non Drinker-vs-Daily Drinker
4.879200E-01
Non Drinker-vs-Weekly Drinker
9.909400E-01
Non Drinker-vs-Occasional Drinker
1.656640E-01
Non Drinker-vs-Social Drinker
2.261400E-01
Daily Drinker-vs-Weekly Drinker
5.939600E-01
Daily Drinker-vs-Occasional Drinker
8.940300E-02
Daily Drinker-vs-Social Drinker
8.946000E-02
Weekly Drinker-vs-Occasional Drinker
2.883200E-01
Weekly Drinker-vs-Social Drinker
2.701800E-01
Occasional Drinker-vs-Social Drinker
8.651800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.185600E-01
Normal-vs-Grade 2
6.275600E-02
Normal-vs-Grade 3
5.058100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.965030E-01
Grade 1-vs-Grade 3
4.458400E-02
Grade 1-vs-Grade 4
2.185600E-01
Grade 2-vs-Grade 3
1.700770E-01
Grade 2-vs-Grade 4
6.275600E-02
Grade 3-vs-Grade 4
5.058100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.518200E-01
Normal-vs-NonDiabetic
6.938200E-01
Diabetic-vs-NonDiabetic
9.303800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.712000E-01
Normal-vs-NoPancreatitis
7.915200E-01
Pancreatitis-vs-NoPancreatitis
5.072000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.435600E-01
Normal-vs-N1
9.530800E-01
N0-vs-N1
3.100600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.992800E-01
Normal-vs-TP53-NonMutant
7.965600E-01
TP53-Mutant-vs-TP53-NonMutant
9.132200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
